Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RhizomK
- Development stage
- Unknown
- Lead developer
- Chemical Resources
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
RhizomK is a proprietary botanical extract derived from the rhizomes of *Curculigo orchioides* (commonly known as black musli), standardized to contain 30% curculigosides. Developed by Chemical Resources (Cheresco), it is positioned as a natural testosterone booster and anabolic support supplement. The extract's primary active constituents, curculigosides, are phenolic phytonutrients hypothesized to optimize male anabolic hormone levels and enhance the physiological response to resistance training. It is currently being evaluated in clinical trials, such as those conducted at the All India Institute of Medical Sciences (AIIMS), Bhubaneswar, to assess its efficacy in increasing free testosterone, improving exercise performance, and enhancing the overall quality of life in healthy, physically active males.
- Brand names
- RhizomK
- Other names
- Curculigo orchioides extractblack musli extract
Beyond the preview
Go deeper on RhizomK.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RhizomK.